Twist Bioscience Corporation - Common Stock (NQ:TWST)

151.97 -3.68 (-2.36%)

Delayed Quote Updated: 11:50 AM EDT, Oct 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Twist Bioscience Corporation - Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Twist Bioscience Now Shipping Synthetic RNA Positive Controls for Delta (B.1.617.2) SARS-CoV-2 Variant for Development of Accurate Diagnostic Tests

July 22, 2021

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience to Report Fiscal 2021 Third Quarter Financial Results on Friday, August 6, 2021

July 21, 2021

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience Acquires NGS Library Preparation Maker iGenomX

June 30, 2021

From Twist Bioscience Corporation

Via Business Wire

Earnings Scheduled For May 6, 2021 ↗

May 06, 2021

Companies Reporting Before The Bell • ViacomCBS (NASDAQ:VIAC) is projected to report quarterly earnings at $1.22 per share on revenue of $7.30 billion. • Cohen...

Via Benzinga

Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge ↗

May 01, 2021

Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...

Via Benzinga

Twist Bioscience Collaborates with Regeneron for Production of Genotyping by Sequencing Panel to Enable Diverse Genome-wide Screening

June 14, 2021

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience Announces Fireside Chat and Presentation at BIO Digital

June 14, 2021

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience Stock Hits 80-Plus Relative Strength Rating Benchmark ↗

June 11, 2021

TwistBioscienceCorp shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 79 to 82.

Via Investor's Business Daily

DNA Data Storage Alliance Publishes First White Paper, Launches Website

June 10, 2021

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience Begins Shipping of Synthetic RNA Controls for Kappa (B.1.617.1) SARS-CoV-2 Variants for Development of Accurate Tests

June 08, 2021

From Twist Bioscience Corporation

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For June 4, 2021 ↗

June 04, 2021

Upgrades According to Argus Research, the prior rating for Diageo PLC (NYSE:DEO) was changed from Hold to Buy. The current stock performance of Diageo shows a 52-week-high...

Via Benzinga

2 Top Biotech Picks to Buy and Hold for the Next 10 Years ↗

May 29, 2021

Incredible scientific advances could reward investors -- if they have the patience.

Via The Motley Fool

Twist Bioscience Stock Scores Relative Strength Rating Upgrade ↗

May 28, 2021

When adding stocks to your watch list, look for stocks with an 80 or higher RS Rating. Twist Bioscience just met that criteria with a new score of 84.

Via Investor's Business Daily

Twist Bioscience Launches Enzymatic Fragmentation Library Preparation Kit for High Uniformity, High-Yield Amplification, Streamlined Next Generation Sequencing Workflow for Targeted Applications

May 25, 2021

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience to Present at Upcoming Virtual Conferences

May 25, 2021

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience Supports the Engineering Biology Research Consortium as it Publishes Statement of Ethics

May 13, 2021

From Twist Bioscience Corporation

Via Business Wire

64 Biggest Movers From Yesterday ↗

May 11, 2021

Gainers InnSuites Hospitality Trust (NYSE: IHT) shares jumped 82.6% to settle at $6.39 on Monday. Protagenic Therapeutics, Inc. (NASDAQ: PTIX) shares surged 53.5% to close at $3....

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

May 10, 2021

Gainers Protagenic Therapeutics (NASDAQ:PTIX) shares increased by 84.03% to $3.92 during Monday's regular session. Trading volume for this security as of 12:30 EST is...

Via Benzinga

Barron's Picks And Pans: Hannon Armstrong, Seagate, Tesla, Virtu Financial And More ↗

May 09, 2021

This weekend's Barron's cover story helps investors to prepare for the changes ahead. Other featured articles discuss how to invest in tomorrow's big tech trends,...

Via Benzinga

What Are the Risks With Twist Bioscience? ↗

May 08, 2021

One especially stands out.

Via The Motley Fool

Twist Bioscience Corp (TWST) Q2 2021 Earnings Call Transcript ↗

May 07, 2021

TWST earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

Twist Bioscience Reports Second Quarter Fiscal 2021 Financial Results

May 06, 2021

From Twist Bioscience Corporation

Via Business Wire

The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom ↗

May 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

Why Does Cathie Wood Like This Healthcare Stock So Much? ↗

May 06, 2021

Twist Bioscience brings to mind another genomic revolution pioneer.

Via The Motley Fool

3 Exciting Biotech Stocks to Buy Right Now ↗

April 30, 2021

Gene therapies could be poised to enter an era of extraordinarily rapid advancement.

Via The Motley Fool

Twist Bioscience and Vivlion Partner to Generate gRNA Libraries for CRISPR Applications

April 28, 2021

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience to Report Fiscal 2021 Second Quarter Financial Results on Thursday, May 6, 2021

April 22, 2021

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience to Expand Oregon Lease, Supporting Future Growth

April 16, 2021

From Twist Bioscience Corporation

Via Business Wire

Pure Biologics Selects Twist Bioscience to Expand Phage Display Technology Capabilities

April 14, 2021

From Twist Bioscience Corporation

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For April 12, 2021 ↗

April 12, 2021

Upgrades For Eni SpA (NYSE:E), Credit Suisse upgraded the previous rating of Underperform to Neutral. For the fourth quarter, Eni had an EPS of $0.02, compared to year-ago...

Via Benzinga

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.